Skip to main content
Fig. 4 | Journal of Orthopaedic Surgery and Research

Fig. 4

From: Comparison between xCELLigence biosensor technology and conventional cell culture system for real-time monitoring human tenocytes proliferation and drugs cytotoxicity screening

Fig. 4

Cell index obtained from the xCELLigence system (a) and results of WST-1 assay upon tenocyte treatment with ketorolac tromethamine (b), bupivacaine (c, d), methylprednisolone (e, f), and betamethasone (g, h). *p < .05. Keto 3, 15, 30: ketorolac tromethamine 3 mg/mL, 15 mg/mL, 30 mg/mL; Bupi 0.05, 0.25, 0.5: bupivacaine 0.05, 0.25, 0.5%; Methyl 4, 20, 40: methylprednisolone 4, 20, 40 mg/mL; Beta 0.7, 3.5, 7: betamethasone 0.7, 3.5, 7 mg/mL

Back to article page